(12-428) Beyfortus® (nirsevimab-alip) Medication Use Evaluation

Wednesday, December 10, 2025

2:00 PM - 3:00 PM

Location: Bayside A, Level 1

Residency Program: Spartanburg Medical Center
Residency Program Type: PGY1 (Pharmacy)
Residency Program Location: South Carolina

Co-Author(s): Sarah Waller, Steven Stoyanov

Primary Author(s)

Maddie L. Treadway, PharmD

PGY1 Pharmacy Resident
Spartanburg Regional Healthcare System